LLNI Funded Publications

The histone deacetylase inhibitor Romidepsin induces as a cascade of differential gene expression and altered Histone H3K9 marks in myeloid leukaemia cells.

Author:Clarke K

Other Authors: Young C, Liberante F, McMullin MF, Thompson A, Mills K,

Last Updated:16/12/2019

Source:a

Type:Journal Article

DOI:10.18632/oncotarget.26877

Journal:Oncotarget

Date: 2019

Link:http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path%5b%5d=26877&path%5b%5d=85040

Follow us
Friends of L&LNI
Get in touch

028 9097 2928
info@llni.co.uk

Leukaemia & Lymphoma NI,
Patrick G Johnston Centre for Cancer Research, 97 Lisburn Rd, Belfast BT9 7AE

© Copyright Leukaemia & Lymphoma NI 2024 | Charity Registration No: 105452 | Privacy Policy